Ophthotech Corporation (ISEE)
(Delayed Data from NSDQ)
$1.43 USD
+0.08 (5.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.43 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ISEE]
Reports for Purchase
Showing records 61 - 80 ( 107 total )
Industry: Medical - Biomedical and Genetics
Pivotal Apellis Top-line Shifts Focus to IVERIC''s Zimura, in Our View
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Prospective Zimura Differentiation at Earlier Stages of AMD Development
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Industry: Medical - Biomedical and Genetics
Will APLS Pony-Up the Results and Read Through to ISEE?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Will APLS Pony-Up the Results and Read Through to ISEE?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Biomedical and Genetics
Targeting Complement Mediated Inflammation and AMD Progression; Initiating With Buy Rating and $20 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Q2 Earnings: We See a Looming Catalyst for ISEE
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D